D-0904-2023 Class II Terminated

Recalled by L. Perrigo Company — Allegan, MI

FDA drug recall D-0904-2023 was initiated by L. Perrigo Company on Feb 9, 2023 and is designated Class II. Reason for recall: Failed Impurities/Degradation Specifications The recall status is terminated (terminated Sep 11, 2023). Affected quantity: 1,920 cartons.

Recall Details

Product Type
Drugs
Report Date
Jul 19, 2023
Initiation Date
Feb 9, 2023
Termination Date
Sep 11, 2023
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
1,920 cartons

Product Description

aller-ease, Fexofenadine Hydrochloride Tablets, 180 mg, 30-count cartons, Packaged For: Your Military Exchanges, By: Perrigo Company, Allegan, MI USA 49010. NDC 55301-847-39

Reason for Recall

Failed Impurities/Degradation Specifications

Distribution Pattern

Nationwide within the USA

Code Information

Lot #: 2ER0285,Exp. date 01/24

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0904-2023
openFDA file date
Nov 3, 2026
Loaded by RegDataLab
Nov 4, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0904-2023. Report a data issue: hello@regdatalab.com.